Erin Benoit Email & Phone Number

Build foundational Global strategic business insights for Astellas’ first approved Ophthalmology treatment, avacincaptad pegol (ACP). Developed Global forecast framework for strategic planning and OUS launch preparation, as well as the integration of US (Izervay) insights following the acquisition of Iveric Bio in 2023. Closely collaborate with Astellas.

XOSPATA Global commercial insights brand lead with deeper engagement in corporate deliverables (Global KPI target setting and achievement, long range forecast improvements, and forecast timeline planning). Collaborate closely with Strategic brand marketing and Medical colleagues to plan for future brand lifecycle management.

Direct Global market research, forecast deliverables, and competitive intelligence for XOSPATA. Global commercial insights main point of contact for over 10 key affiliates as XOSPATA is launched globally.

Undertook new leadership roles for XOSPATA which included creating and presenting the Situation Analysis to inform strategic planning, uncovered performance barriers via research and analytics, developed division and Global KPIs, and worked closely with Global colleagues on a unified Global forecasting model. Additionally supported the Astellas Oncology.

Led the U.S. XOSPATA launch preparation and foundational physician/patient market insights and long-term forecast to inform commercial brand marketing. XOSPATA received FDA approval for FLT3+ Relapse/Refractory Acute Myeloid Leukemia in November, 2018. Identified key market trends as the brand and AML market evolved during the initial launch phase.

Led the forecasting, market research, and analytics for commercial assessments of pipeline assets and licensing targets across a wide variety of therapeutic areas/spaces (e.g., genitourinary, muscle, vaccines, immunology, ophthalmology, orphan diseases). Built the U.S. forecast for Astellas' largest non-oncology acquisition to date (Ogeda - fezolinetant)..

Led payer-focused market intelligence research for key Astellas therapeutic areas and business development opportunities in order to inform the marketing strategy and resource allocation.

Valby, Copenhagen, DK

Assessed the sales potential of the entire domestic portfolio of Lundbeck on-market products for the Neurology and Psychiatry franchises. This included close collaboration with market research, commercial, regulatory, manufacturing, and clinical teams to gather feedback on key assumptions and present findings and recommendations to senior management.

Abbott Park, Illinois, US

Created and maintained forecast models for key Abbott pipeline compounds in the Pain and Women's Health franchises, as well as forecasting for business development (licensing and M&A) opportunities.

Abbott Park, Illinois, US

Designed, developed, and presented physician-focused primary and secondary market research studies for HUMIRA (Abbott's largest pharmaceutical)

Abbott Park, Illinois, US

Led payer research and analytics within the highly complex U.S. managed care environment to inform marketing and sales strategic decision making.

Abbott Park, Illinois, US

Analyzed the profitabilty, utilization, and market share of National and Regional health plan contracts.

Chicago, IL, US

Researched historical and forecasted market demand and schedule gaps to determine optimal profit opportunities for additional destinations in United's flight schedule.

Chicago, IL, US

Determined pricing for published and internet airfares.

Mba, Marketing/Management

Accounting And Marketing

Bachelor Of Science - Bs, Accounting And Marketing